Intellia Therapeutics, Inc. (NTLA)
NASDAQ: NTLA · Real-Time Price · USD
9.47
+0.25 (2.66%)
Mar 14, 2025, 9:51 AM EDT - Market open
Intellia Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | -519.02 | -481.19 | -474.19 | -267.89 | -134.23 | |
| Depreciation & Amortization | 10.29 | 8.98 | 7.57 | 6.89 | 6.31 | |
| Loss (Gain) From Sale of Assets | -0.08 | 0.07 | -0.16 | - | 0.04 | |
| Asset Writedown & Restructuring Costs | - | - | 55.99 | - | - | |
| Loss (Gain) From Sale of Investments | -6.22 | -19.27 | 15.41 | 10.54 | 0.54 | |
| Loss (Gain) on Equity Investments | - | 15.63 | 11.08 | 1.33 | - | |
| Stock-Based Compensation | 154.27 | 134.05 | 91.4 | 47.01 | 19.9 | |
| Other Operating Activities | - | 0.1 | 13.49 | - | - | |
| Change in Accounts Receivable | 27.94 | -32.69 | -1.74 | 0.1 | 2.49 | |
| Change in Accounts Payable | 6.8 | 2.52 | -4.58 | 0.53 | 5.06 | |
| Change in Unearned Revenue | -22.08 | -2.78 | -63.46 | -31.36 | 45.12 | |
| Change in Other Net Operating Assets | -0.79 | -19.51 | 15.91 | 7.82 | 4.86 | |
| Operating Cash Flow | -348.88 | -394.09 | -333.29 | -225.03 | -49.91 | |
| Capital Expenditures | -5.78 | -13.99 | -13.56 | -12.76 | -3.59 | |
| Sale of Property, Plant & Equipment | - | - | 0.15 | - | - | |
| Sale (Purchase) of Intangibles | - | - | -44.83 | - | - | |
| Investment in Securities | 131.35 | -17.36 | 218.55 | -538.02 | -210.9 | |
| Investing Cash Flow | 125.57 | -31.35 | 160.31 | -550.78 | -214.49 | |
| Issuance of Common Stock | 185.75 | 130.32 | 582.96 | 736.69 | 371.78 | |
| Financing Cash Flow | 185.75 | 130.32 | 582.96 | 736.69 | 371.78 | |
| Net Cash Flow | -37.57 | -295.11 | 409.98 | -39.12 | 107.38 | |
| Free Cash Flow | -354.66 | -408.07 | -346.85 | -237.79 | -53.5 | |
| Free Cash Flow Margin | -612.78% | -1124.94% | -665.46% | -719.41% | -92.25% | |
| Free Cash Flow Per Share | -3.59 | -4.60 | -4.51 | -3.35 | -0.96 | |
| Levered Free Cash Flow | -133.38 | -268.21 | -256.18 | -69.57 | -43.46 | |
| Unlevered Free Cash Flow | -133.38 | -268.21 | -256.18 | -69.57 | -43.46 | |
| Change in Net Working Capital | -41.76 | 75.19 | 10.41 | -56.69 | -19.28 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.